Getting To A Rule For Reverse Payments
For a decade now, courts have been grappling with whether so-called "reverse payments" by pioneer pharmaceutical manufacturers to generic competitors in settlement of patent infringement litigation violate the antitrust laws, and...To view the full article, register now.
Already a subscriber? Click here to view full article